By Huang Jianwen King and Wood Mallesons’ Commercial & Regulatory Group

huang_jianwenAlong with the rapid development of the healthcare and pharmaceutical industry, various key policies have been published recently. This article will sort out China’s key regulations and policies in 2015 related to drugs from three aspects – drug prices, drug evaluations, and drug procurements.